DERMライブシグナル | Getagraph.comで利益を最大化

買う 109567 min ago

@ $4.83

発行日: 13 2月 2024 @ 23:36

リターン: -30.23%

前回のシグナル: 2月 7 - 03:59

前回のシグナル: 売る

リターン: 10.02 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:35):

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States...

Stats
本日の出来高	31 846.00
平均出来高	163 943
時価総額	66.77M
EPS	$0 ( 2024-03-21 )
次の収益日	( $-0.260 ) 2024-05-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-16.05
ATR14	$0.0230 (0.68%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-25	Rosenwald Lindsay A Md	Buy	10 000	Common Stock, $0.0001 par value
2024-03-22	Maraoui Claude	Buy	10 000	Common Stock, $0.0001 par value
2024-03-22	Smith Justin Adam	Buy	30 000	Common Stock, $0.0001 par value
2024-03-22	Rosenwald Lindsay A Md	Buy	20 000	Common Stock, $0.0001 par value
2024-02-22	Benesch Joseph	Sell	2 450	Common Stock, $0.0001 par value

INSIDER POWER
75.75
Last 94 transactions
Buy: 1 155 250 \| Sell: 1 927 470

ボリューム相関

長: -0.07 (neutral)

短: -0.51 (weak negative)

Signal:(47.991) Neutral

Dermira Inc. 相関

10 最も正の相関
RMRM	0.942
VVOS	0.891
GETVV	0.878
XCUR	0.854
GAINL	0.846
ACST	0.825
GLMD	0.825
PASG	0.809

10 最も負の相関
AMRB	-0.849
OZK	-0.815
SJ	-0.814

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Dermira Inc. 相関 - 通貨/商品

-0.67
( moderate negative )

-0.69
( moderate negative )

0.00
( neutral )

-0.61
( weak negative )

0.50
( weak )

0.68
( moderate )

Dermira Inc. 財務諸表

Annual	2023
収益:	$79.18M
総利益:	$52.52M (66.33 %)
EPS:	$-0.210

FY	2023
収益:	$79.18M
総利益:	$52.52M (66.33 %)
EPS:	$-0.210

FY	2022
収益:	$73.67M
総利益:	$42.89M (58.23 %)
EPS:	$-1.690

FY	2021
収益:	$63.13M
総利益:	$31.05M (49.18 %)
EPS:	$-2.68

Financial Reports:

No articles found.

Dermira Inc.

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.